# Gralise

NDC: 52427-804
Generic name: gabapentin
Labeler / Manufacturer: Almatica Pharma LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20231231

FDA application: NDA022544

## Active ingredients

- GABAPENTIN: 450 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"52427-804"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=52427-804
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=466273b1-c9fc-3930-c94b-aa11394d5140